No profile data available.
Champions Oncology, Inc. (CSBR) is a healthcare company in the early-stage drug development research industry, based in Hackensack, United States, with about 214 full-time employees.
It reported revenue of $59.43 million for fiscal year 2026, up 4.4% from fiscal year 2025, and net income of -$1.18 million. In Q1 2027 (the quarter ended July 31, 2026) revenue was $15.23 million, up 8.8% from a year before. Its market capitalization was $67.37 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended April 30, 2026; market data as of October 9, 2026.
, a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform.
Champions Oncology reported $59.43 million in revenue for fiscal year 2026, up 4.4% from $56.94 million in fiscal year 2025. In Q1 2027 revenue was $15.23 million.
$67.37 million as of October 9, 2026.
Listed companies of a similar size in the same industry (early-stage drug development research) include Charles River Laboratories International, Inc. (CRL), Bioqual, Inc. (BIOQ).